These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 4072077)

  • 1. [Multivariate discriminant analysis--a current method for evaluating the enzyme spectrum in cancer patients].
    Klöppel R; Kamprad F; Winiecki P
    Vopr Onkol; 1985; 31(11):11-3. PubMed ID: 4072077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The study of some enzymatic changes in cancer patients with the aid of modern technics].
    Mera A; Nistor C; Onisor M; Marozis I; Bertalan G
    Viata Med Rev Inf Prof Stiint Cadrelor Medii Sanit; 1982 Jan; 30(1):17-9. PubMed ID: 6812278
    [No Abstract]   [Full Text] [Related]  

  • 3. [Multivariate discrimination analysis of enzyme patterns in tumor patients].
    Klöppel R; Zöllner H; Wieniecki P; Kamprad F; Oelssner W
    Radiobiol Radiother (Berl); 1982 Mar; 23(2):127-33. PubMed ID: 7100419
    [No Abstract]   [Full Text] [Related]  

  • 4. [The precipitin test for cancer, serum hexokinase and polarography for recognition of malignant tumors].
    Gnatyshak EA
    Vrach Delo; 1972 Dec; 12():96-7. PubMed ID: 4659232
    [No Abstract]   [Full Text] [Related]  

  • 5. Human tumors by NMR.
    Damadian R; Zaner K; Hor D; Dimaio T
    Physiol Chem Phys; 1973; 5(5):381-402. PubMed ID: 4775587
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnosis of tumor by ultrasound.
    Holmes JH
    Prog Clin Cancer; 1967; 3():135-50. PubMed ID: 4867087
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of urinary NMP22 (nuclear matrix protein 22) as a diagnostic marker for urothelial cancer--NMP22 as a urinary marker for surveillance of bladder cancer. NMP22 Study Group].
    Akaza H; Miyanaga N; Tsukamoto T; Ishikawa S; Noguchi R; Ohtani M; Kawabe K; Kubota Y; Fujita K; Obata K; Hirao Y; Kotake T; Ohmori H; Kumazawa J; Koiso K
    Gan To Kagaku Ryoho; 1997 May; 24(7):829-36. PubMed ID: 9170521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic studies in cancer of the breast: optimal use of current statistical tools].
    Bonichon F
    Bull Cancer; 1996 Dec; 83(12):1046-52. PubMed ID: 9116374
    [No Abstract]   [Full Text] [Related]  

  • 9. Detection of human telomerase reverse transcriptase messenger RNA in voided urine samples as a useful diagnostic tool for bladder cancer.
    Ito H; Kyo S; Kanaya T; Takakura M; Koshida K; Namiki M; Inoue M
    Clin Cancer Res; 1998 Nov; 4(11):2807-10. PubMed ID: 9829746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative evaluation of the diagnostic performance of the BTA stat test, NMP22 and urinary bladder cancer antigen for primary and recurrent bladder tumors.
    Giannopoulos A; Manousakas T; Gounari A; Constantinides C; Choremi-Papadopoulou H; Dimopoulos C
    J Urol; 2001 Aug; 166(2):470-5. PubMed ID: 11458049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of serum and urine clusterin as a potential tumor marker for urinary bladder cancer.
    Stejskal D; Fiala RR
    Neoplasma; 2006; 53(4):343-6. PubMed ID: 16830064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention practices and cancer screening among general practitioners in Picardy (France)].
    Ganry O; Boche T
    Bull Cancer; 2004 Oct; 91(10):785-91. PubMed ID: 15556879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer presenting initially with urinary incontinence: a case of bladder metastasis from breast cancer.
    Soon PS; Lynch W; Schwartz P
    Breast; 2004 Feb; 13(1):69-71. PubMed ID: 14759720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Zymography--method for quantitation of activity on gelatinase A (pro-MMP-2, 72 kDa) and gelatinase B (pro-MMP-9, 92 kDa) in serum of patients with breast cancer].
    Sliwowska I; Kopczyński Z
    Wiad Lek; 2007; 60(5-6):241-7. PubMed ID: 17966888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Endobronchial metastases (author's transl)].
    Bohut V; Macholda F
    Z Erkr Atmungsorgane; 1981 May; 157(2):219-22. PubMed ID: 7314696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
    Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
    Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of cytodiagnosis and biopsy in early diagnosis of cancer--from the viewpoint of cytodiagnosis].
    Matsuda M
    Rinsho Byori; 1983 Dec; 31 Suppl():57-69. PubMed ID: 6376865
    [No Abstract]   [Full Text] [Related]  

  • 19. [Serum enzymes in Hodgkin's disease, breast carcinoma and testicular tumors].
    Pfeiffer R; Hirche H; Schmidt CG
    Verh Dtsch Ges Inn Med; 1975; 81():1606-8. PubMed ID: 1241639
    [No Abstract]   [Full Text] [Related]  

  • 20. [Delay in the diagnosis of malignant tumors (breast, larynx, bladder)].
    Ares Camerino A; Escolar Pujolar A; Sáinz Vera B
    Rev Clin Esp; 1995 Dec; 195(12):825-9. PubMed ID: 8599038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.